Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" ...

Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...

Marketresearch.biz reports that the Bioburden Testing Market size is expected to be worth around USD 4.93 Billion by 2033, from USD 1.35 Billion in 2023, growing at a CAGR of 14.20% during the ...

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The Bioburden Testing Market is ...

Marketresearch.biz reports that the Rising investments by companies on R&D in lifesciences and increasing product recalls due to microbial contamination are other factors driving growth of the target ...

As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...

Another driver contributing to the market growth is the growing emphasis on regulatory compliance. Regulatory authorities across the globe are imposing strict guidelines and regulations regarding ...